Functional genomics approaches to improve pre‐clinical drug screening and biomarker discovery
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Functional genomics approaches to improve pre‐clinical drug screening and biomarker discovery
Authors
Keywords
-
Journal
EMBO Molecular Medicine
Volume 13, Issue 9, Pages -
Publisher
EMBO
Online
2021-07-13
DOI
10.15252/emmm.202013189
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer research needs a better map
- (2021) Jesse S. Boehm et al. NATURE
- Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts
- (2021) Xing Yi Woo et al. NATURE GENETICS
- Combinatorial CRISPR screen identifies fitness effects of gene paralogues
- (2021) Nicola A. Thompson et al. Nature Communications
- Integrated cross-study datasets of genetic dependencies in cancer
- (2021) Clare Pacini et al. Nature Communications
- Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing
- (2021) Mitchell L. Leibowitz et al. NATURE GENETICS
- Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response
- (2021) Dimitra Georgopoulou et al. Nature Communications
- Deciphering the signaling network of breast cancer improves drug sensitivity prediction
- (2021) Marco Tognetti et al. Cell Systems
- Synthetic lethality between VPS 4A and VPS 4B triggers an inflammatory response in colorectal cancer
- (2020) Ewelina Szymańska et al. EMBO Molecular Medicine
- A reference map of the human binary protein interactome
- (2020) Katja Luck et al. NATURE
- CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities
- (2020) Kyuho Han et al. NATURE
- Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts
- (2020) Kwanghee Kim et al. Nature Communications
- CELLector: Genomics-Guided Selection of Cancer In Vitro Models
- (2020) Hanna Najgebauer et al. Cell Systems
- Current Strategies and Future Directions to Achieve Deep Molecular Response and Treatment-Free Remission in Chronic Myeloid Leukemia
- (2020) Mario Annunziata et al. Frontiers in Oncology
- The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development
- (2020) Nallasivam Palanisamy et al. CLINICAL CANCER RESEARCH
- Patient-derived xenografts (PDXs) as model systems for human cancer
- (2020) Federica Invrea et al. CURRENT OPINION IN BIOTECHNOLOGY
- High-performance CRISPR-Cas12a genome editing for combinatorial genetic screening
- (2020) Rodrigo A. Gier et al. Nature Communications
- A Three-Way Combinatorial CRISPR Screen for Analyzing Interactions among Druggable Targets
- (2020) Peng Zhou et al. Cell Reports
- Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells
- (2020) Xiaolong Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids
- (2020) Brooke Schuster et al. Nature Communications
- Multi-site clonality analysis uncovers pervasive heterogeneity across melanoma metastases
- (2020) Roy Rabbie et al. Nature Communications
- In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells
- (2020) M. Martinez-Lage et al. Nature Communications
- 3D Culture Models with CRISPR Screens Reveal Hyperactive NRF2 as a Prerequisite for Spheroid Formation via Regulation of Proliferation and Ferroptosis
- (2020) Nobuaki Takahashi et al. MOLECULAR CELL
- Synthetic Lethal Interaction between the ESCRT Paralog Enzymes VPS4A and VPS4B in Cancers Harboring Loss of Chromosome 18q or 16q
- (2020) Jasper E. Neggers et al. Cell Reports
- Combinatorial Genetics Reveals a Scaling Law for the Effects of Mutations on Splicing
- (2019) Pablo Baeza-Centurion et al. CELL
- Update on emerging biomarkers in lung cancer
- (2019) Eric H. Bernicker et al. Journal of Thoracic Disease
- Genome-scale drop-out screens to identify cancer cell vulnerabilities in AML
- (2019) Faisal T Basheer et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- WRN helicase is a synthetic lethal target in microsatellite unstable cancers
- (2019) Edmond M. Chan et al. NATURE
- Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
- (2019) Fiona M. Behan et al. NATURE
- Xenograft and organoid model systems in cancer research
- (2019) Margit Bleijs et al. EMBO JOURNAL
- The novel BET‐CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild‐type prostate cancer
- (2019) Yuqian Yan et al. EMBO Molecular Medicine
- Targeting Oncogenic BRAF: Past, Present, and Future
- (2019) Zaman et al. Cancers
- Synthetic lethality as an engine for cancer drug target discovery
- (2019) Alan Huang et al. NATURE REVIEWS DRUG DISCOVERY
- Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types
- (2019) K. Yu et al. Nature Communications
- Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening
- (2019) Minsuh Kim et al. Nature Communications
- Agreement between two large pan-cancer CRISPR-Cas9 gene dependency data sets
- (2019) Joshua M. Dempster et al. Nature Communications
- A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
- (2018) Norman Sachs et al. CELL
- Dual inhibition of AKT‐mTOR and AR signaling by targeting HDAC3 in PTEN ‐ or SPOP ‐mutated prostate cancer
- (2018) Yuqian Yan et al. EMBO Molecular Medicine
- Personalized Cancer Medicine: An Organoid Approach
- (2018) Hamidreza Aboulkheyr Es et al. TRENDS IN BIOTECHNOLOGY
- A microfluidics platform for combinatorial drug screening on cancer biopsies
- (2018) Federica Eduati et al. Nature Communications
- Intra-tumour diversification in colorectal cancer at the single-cell level
- (2018) Sophie F. Roerink et al. NATURE
- Genetic and transcriptional evolution alters cancer cell line drug response
- (2018) Uri Ben-David et al. NATURE
- Cell Model Passports—a hub for clinical, genetic and functional datasets of preclinical cancer models
- (2018) Dieudonne van der Meer et al. NUCLEIC ACIDS RESEARCH
- Organoid Modeling of the Tumor Immune Microenvironment
- (2018) James T. Neal et al. CELL
- Cancer biomarker discovery and translation: proteomics and beyond
- (2018) Ventzislava A. Hristova et al. Expert Review of Proteomics
- Chimeric Antigen Receptor–modified T Cells Repressed Solid Tumors and Their Relapse in an Established Patient-derived Colon Carcinoma Xenograft Model
- (2018) Ruidi Teng et al. JOURNAL OF IMMUNOTHERAPY
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- (2018) Kathleen Moore et al. NEW ENGLAND JOURNAL OF MEDICINE
- COSMIC: the Catalogue Of Somatic Mutations In Cancer
- (2018) John G Tate et al. NUCLEIC ACIDS RESEARCH
- Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2017) Eric Pujade-Lauraine et al. LANCET ONCOLOGY
- Patient-derived xenografts undergo mouse-specific tumor evolution
- (2017) Uri Ben-David et al. NATURE GENETICS
- Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases
- (2017) Arnaud Blomme et al. ONCOGENE
- Identification and causes of metabonomic difference between orthotopic and subcutaneous xenograft of pancreatic cancer
- (2017) Bohan Zhan et al. Oncotarget
- A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma
- (2017) Clemens Krepler et al. Cell Reports
- Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized Medicine
- (2017) Katherine M. Morgan et al. Frontiers in Oncology
- A Biomarker Harvest from One Thousand Cancer Cell Lines
- (2016) Yu-Han Huang et al. CELL
- A Landscape of Pharmacogenomic Interactions in Cancer
- (2016) Francesco Iorio et al. CELL
- A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds
- (2016) Alejandra Bruna et al. CELL
- Modeling Development and Disease with Organoids
- (2016) Hans Clevers CELL
- Drug response consistency in CCLE and CGP
- (2016) Mehdi Bouhaddou et al. NATURE
- Consistency in drug response profiling
- (2016) John Patrick Mpindi et al. NATURE
- Consistency in large pharmacogenomic studies
- (2016) Paul Geeleher et al. NATURE
- Theranostic barcoded nanoparticles for personalized cancer medicine
- (2016) Zvi Yaari et al. Nature Communications
- In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer
- (2016) Alessandro Carugo et al. Cell Reports
- Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening
- (2016) Carla S Verissimo et al. eLife
- Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
- (2015) Marc van de Wetering et al. CELL
- Spatial intra-tumour heterogeneity in acquired resistance to targeted therapy complicates the use of PDX models for co-clinical cancer studies
- (2015) C. Wellbrock EMBO Molecular Medicine
- Intra- and inter-tumor heterogeneity in a vemurafenib-resistant melanoma patient and derived xenografts
- (2015) K. Kemper et al. EMBO Molecular Medicine
- Pharmacogenomic agreement between two cancer cell line data sets
- (2015) Nicolas Stransky et al. NATURE
- Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell– and patient-derived tumor organoids
- (2015) Ling Huang et al. NATURE MEDICINE
- High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
- (2015) Hui Gao et al. NATURE MEDICINE
- Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases
- (2015) Fleur Weeber et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer
- (2015) Muhammed Murtaza et al. Nature Communications
- Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset
- (2015) B. Seashore-Ludlow et al. Cancer Discovery
- Organoid Cultures Derived from Patients with Advanced Prostate Cancer
- (2014) Dong Gao et al. CELL
- A Proteome-Scale Map of the Human Interactome Network
- (2014) Thomas Rolland et al. CELL
- Organoid cultures for the analysis of cancer phenotypes
- (2014) Norman Sachs et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12
- (2014) A. Duquet et al. EMBO Molecular Medicine
- Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution
- (2014) Peter Eirew et al. NATURE
- A comprehensive transcriptional portrait of human cancer cell lines
- (2014) Christiaan Klijn et al. NATURE BIOTECHNOLOGY
- Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
- (2014) M. Hidalgo et al. Cancer Discovery
- Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies
- (2014) Glenn S Cowley et al. Scientific Data
- GRP78 secreted by tumor cells stimulates differentiation of bone marrow mesenchymal stem cells to cancer-associated fibroblasts
- (2013) Yanan Peng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
- (2013) X. Zhang et al. CANCER RESEARCH
- Metabolomics in cancer biomarker discovery: Current trends and future perspectives
- (2013) Emily G. Armitage et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Inconsistency in large pharmacogenomic studies
- (2013) Benjamin Haibe-Kains et al. NATURE
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global Proteome Analysis of the NCI-60 Cell Line Panel
- (2013) Amin Moghaddas Gholami et al. Cell Reports
- Characterization of a Large Panel of Patient-Derived Tumor Xenografts Representing the Clinical Heterogeneity of Human Colorectal Cancer
- (2012) S. Julien et al. CLINICAL CANCER RESEARCH
- Oncogene addiction
- (2012) Jeffrey Settleman CURRENT BIOLOGY
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
- (2012) Wanjuan Yang et al. NUCLEIC ACIDS RESEARCH
- Interactome Networks and Human Disease
- (2011) Marc Vidal et al. CELL
- Single-cell dissection of transcriptional heterogeneity in human colon tumors
- (2011) Piero Dalerba et al. NATURE BIOTECHNOLOGY
- Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
- (2011) Yoko S DeRose et al. NATURE MEDICINE
- A Molecularly Annotated Platform of Patient-Derived Xenografts ("Xenopatients") Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
- (2011) A. Bertotti et al. Cancer Discovery
- High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing
- (2011) David Sims et al. GENOME BIOLOGY
- Human cancer cell lines: Experimental models for cancer cells in situ? For cancer stem cells?
- (2009) W.C.G. van Staveren et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Establishment of Patient-Derived Non-Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers
- (2008) I. Fichtner et al. CLINICAL CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started